The burden of disease due to malaria in Uganda is unacceptably high and the resistance of the malaria parasites to Chloroquine (CQ) and Sulfadoxine/Pyrimethamine (SP) has aggravated the situation. Because of this, in May 2004, the Ministry of Health decided to change the malaria treatment policy from CQ+SP combination to the more effective artemisinin based combination therapy (ACT).
0 Comments